Overview

A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
Single centre, open-label, multiple doses, one-sequence design study in two parallel groups of healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Bial - Portela C S.A.
Treatments:
Eslicarbazepine acetate
Topiramate